Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats

Neuroscience

Volumn 81, Issue 4, 1997, Pages 1009-1017

  Felix, R ^a   Levin, E D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dihydro erythroidine; Hippocampus; Memory; Methyllycaconitine; Nicotinic; Radial arm maze

Indexed keywords

NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT;

ACETYLCHOLINE BRAIN LEVEL; AMNESIA; ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; HIPPOCAMPUS; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; TASK PERFORMANCE;

ACONITINE; ANIMALS; CHOLINERGIC ANTAGONISTS; DIHYDRO-BETA-ERYTHROIDINE; FEMALE; HIPPOCAMPUS; MAZE LEARNING; MEMORY, SHORT-TERM; NEUROMUSCULAR BLOCKING AGENTS; NICOTINIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; SPACE PERCEPTION; TUBOCURARINE;

EID: 0031563811     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00224-8     Document Type: Article

References (55)

1. Aiyar V. N., Benn M. H., Hanna T., Jacyno L., Roth S. H., Wilkens J. L. The principal toxin of Delphinium brownii, and its mode of action. Experientia. 35:1979;1367-1378.
2. Alkondon M., Albuquerque E. X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. 1. Pharmacological and functional evidence for distinct structural subtypes. J. Pharmac. exp. Ther. 265:1993;1455-1473.
3. Alkondon M., Albuquerque E. X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. 3. Agonist actions of the novel alkaloid epibatidine and analysis of type II current. J. Pharmac. exp. Ther. 274:1995;771-782.
4. Alkondon M., Pereira E. R., Wonnacott S., Albuquerque E. X. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Molec. Pharmac. 41:1992;802-808.
5. Barrantes G. E., Murphy C. T., Westwick J., Wonnacott S. Nicotine increases intracellular calcium in rat hippocampal neurons via voltage-gated calcium channels. Neurosci. Lett. 196:1995;101-104.
6. Briggs C. A., McKenna D. G., Piattoni-Kaplan M. Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands. Neuropharmacology. 34:1995;583-590.
7. Brioni J. D., Decker M. W., Sullivan J. P., Arneric S. P. The pharmacology of (-)-nicotine and novel cholinergic channel modulators. Adv. Pharmac. 37:1997;153-214.
8. Brioni J. D., Kim D. J. B., Oneill A. B. Nicotine cue: lack of effect of the alpha 7 nicotinic receptor antagonist methyllycaconitine. Eur. J. Pharmac. 301:1996;1-5.
9. Cachelin A. B., Rust G. Unusual pharmacology of (+)-tubocurarine with rat neuronal nicotinic acetylcholine receptors containing beta 4 subunits. Molec. Pharmac. 46:1994;1168-1174.
10. Castro N. G., Albuquerque E. X. Brief-lifetime, fast-inactivating ion channels account for the alpha-bungarotoxin-sensitive nicotinic response in hippocampal neurons. Neurosci. Lett. 164:1993;137-140.
11. Collins A. C., Evans C. B., Miner L. L., Marks M. J. Mecamylamine blockade of nicotine responses: evidence for two brain nicotinic receptors. Pharmac. Biochem. Behav. 24:1986;1767-1773.
12. Connolly J., Boulter J., Heinemann S. F. Alpha4-2beta2 and other nicotinic acetylcholine receptor subtypes as targets of psychoactive and addictive drugs. Br. J. Pharmac. 105:1992;657-666.
13. Court J., Clementi F. Distribution of nicotinic subtypes in human brain. Alz. Dis. Assoc. Disord. 9:1995;6-14.
14. Curzon P., Brioni J. D., Decker M. W. Effect of intraventricular injections of dihydro-beta-erythroidine (DHBE) on spatial memory in the rat. Brain Res. 714:1996;185-191.
15. Damaj M. I., Welch S. P., Martin B. R. In vivo pharmacological effects of dihydro-beta-erythroidine, a nicotinic antagonist, in mice. Psychopharmacology. 117:1995;67-73.
16. Dasheiff R. M. D-Tubocurarine causes neuronal death when injected directly into rat brain. Expl Neurol. 89:1985;172-188.
17. Decker M. W., Brioni J. D., Bannon A. W., Arneric S. P. Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics - minireview. Life Sci. 56:1995;545-570.
18. Decker M. W., Curzon P., Brioni J. D., Arneric S. P. Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats. Eur. J. Pharmac. 261:1994;217-222.
19. Decker M. W., Majchrzak M. J., Arneric S. P. Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmac. Biochem. Behav. 45:1993;571-576.
20. 125I-alpha-bungarotoxin receptor subtypes. Molec. Pharmac. 47:1995;164-171.
21. Freund R. K., Jungschaffer D. A., Collins A. C. Nicotine effects in mouse hippocampus are blocked by mecamylamine, but not other nicotinic antagonists. Brain Res. 511:1990;187-191.
22. Galzi J. L., Changeux J. P. Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology. 34:1995;563-582.
23. Garcia-Ugalde G., Tapia R. Convulsions and wet-dog shakes produced by systemic or intrahippocampal administration of ruthenium red in the rat. Expl Brain Res. 86:1991;633-640.
24. Gotti C., Hanke W., Schlue W. R., Briscini L., Moretti M., Clementi F. A functional alpha-bungarotoxin receptor is present in chick cerebellum: purification and characterization. Neuroscience. 50:1992;117-127.
25. Granon S., Poucet B., Thinusblanc C., Changeux J. P., Vidal C. Nicotinic and muscarinic receptors in the rat prefrontal cortex: differential roles in working memory, response selection and effortful processing. Psychopharmacology. 119:1995;139-144.
26. Hardick D. J., Cooper G., Scott-Ward T., Blagbrough I. S., Potter B. V., Wonnacott S. Conversion of the sodium channel activator aconitine into a potent alpha 7-selective nicotinic ligand. Fedn Eur. biochem. Socs Lett. 365:1995;79-82.
27. Hunter B. E., de Fiebre C. M., Papke R. L., Kem W. R., Meyer E. M. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci. Lett. 168:1994;130-134.
28. Jackson W. J., Elrod K. and Buccaftisco J. J. (1989) Delayed matching-to-sample in monkeys as a model for learning and memory deficits: role of brain nicotinic receptors. In Novel Approaches to the Treatment of Alzheimer's Disease (eds Meyer E. M., Simpkins J. W. and Yamamoto J.), pp. 39-52. Plenum, New York.
29. Kim J., Levin E. Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens: effects on spatial working memory in rats. Brain Res. 725:1996;231-240.
30. Levin E. D. Psychopharmacological effects in the radial-arm maze. Neurosci. Biobehav. Rev. 12:1988;169-175.
31. Levin E. D. Nicotinic systems and cognitive function. Psychopharmacology. 108:1992;417-431.
32. Levin E. D. Nicotinic agonist and antagonist effects on memory. Drug Dev. Res. 38:1996;188-195.
33. Levin E. D., Briggs S. J., Christopher N. C., Auman J. T. Working memory performance and cholinergic effects in the ventral tegmental area and substantia nigra. Brain Res. 657:1994;165-170.
34. Levin E. D., Rose J. E., Abood L. Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze. Pharmac. Biochem. Behav. 51:1995;369-373.
35. Luetje C. W., Wada K., Rogers S., Abramson S. N., Tsuji K., Heinemann S., Patrick J. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations. J. Neurochem. 55:1990;632-640.
36. Luntz-Leybman V., Bickford P. C., Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 587:1992;130-136.
37. McGehee D. S., Heath M. J. S., Gelber S., Devay P., Role L. W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 269:1995;1692-1696.
38. McGehee D. S., Role L. W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. A. Rev. Physiol. 57:1995;521-546.
39. Meyer E. M., de Fiebre C. M., Hunter B. E., Simpkins C. E., Frauworth N., de Fiebre N. E. Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev. Res. 31:1994;127-134.
40. Miner L. L., Marks M. J., Collins A. C. Relationship between nicotine-induced seizures and hippocampal nicotinic receptors. Life Sci. 37:1985;75-83.
41. Newhouse P. A., Potter A., Corwin J., Lenox R. Modeling the nicotinic receptor loss in dementia using the nicotinic antagonist mecamylamine: effects on human cognitive functioning. Drug Dev. Res. 31:1994;71-79.
42. Newhouse P. A., Sunderland T., Tariot P. N., Blumhardt C. L., Weingartner H., Mellow A., Murphy D. L. Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology. 95:1988;171-175.
43. Ohno M., Yamamoto T., Watanabe S. Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats. Pharmac. Biochem. Behav. 45:1993;89-93.
44. Palma E., Bertrand S., Binzoni T., Bertrand D. Neuronal nicotinic alpha 7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine. Physiology. 491:1996;151-161.
45. Pellegrino L. J., Pellegrino A. S. and Cushman A. J. (1979) A Stereotaxic Atlas of the Rat Brain, 2nd edn. Plenum, New York.
46. Perry E. Cholinergic signaling in Alzheimer disease: therapeutic strategies. Alz. Dis. Assoc. Disord. 9:1995;1-2.
47. Rondouin G., Lerner-Natoli M., Hashizume A. Wet dog shakes in limbic versus generalized seizures. Expl Neurol. 95:1987;500-505.
48. Ward J. M., Cockcroft V. B., Lunt G. G., Smillie F. S., Wonnacott S. Methyllycaconitine: a selective probe for neuronal alpha-bungarotoxin binding sites. Fedn Eur. biochem. Socs Lett. 270:1990;45-48.
49. Whitehouse P. J., Kalaria R. N. Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. Alz. Dis. Assoc. Disord. 9:1995;35.
50. 3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology. 38:1988;720-723.
51. Whiting P., Schoepfer R., Lindstrom J., Priestley T. Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Molec. Pharmac. 40:1991;463-472.
52. Wilkie G. I., Hutson P. H., Stephens M. W., Whiting P., Wonnacott S. Hippocampal nicotinic autoreceptors modulate acetylcholine release. Biochem. Soc. Trans. 21:1993;429-431.
53. Wong L. A., Gallagher J. P. Pharmacology of nicotinic receptor mediated inhibition in rat dorsolateral septal neurones. J. Physiol. 436:1990;325-346.
54. Wonnacott S., Irons J., Rapier C., Thorne B. and Lunt G. G. (1989) Presynaptic modulation of transmitter release by nicotinic receptors. In Progress In Brain Research (eds Nordberg A., Fuxe K., Holmstedt B. and Sundwall A.), pp. 157-163. Elsevier Science, Amsterdam.
55. Woodruffpak D. S., Li Y. T., Kem W. R. A nicotinic agonist (GTS-21), eyeblink classical conditioning, and nicotinic receptor binding in rabbit brain. Brain Res. 645:1994;309-317.